Pfizer Inc at Cowen Health Care Conference (Virtual) Transcript
Well, good morning, and welcome to the Pfizer session of Cowen's 42nd Annual Healthcare Conference. We're very pleased to have top management of Pfizer with us this morning. Representing the company, Angela Hwang, who's Group President, Pfizer Biopharmaceuticals Group; Andy Schmeltz, who is Global President and General Manager of Pfizer Oncology; and Suneet Varma, who is Global President of Pfizer Rare Disease.
Before we get underway with the questions, I would like to remind investors that at Cowen, we are recommending Pfizer shares because we believe the new product flow and the growth prospects that will stem from those new products are not reflected in the multiple, making the shares very attractive in our view.
So we'll start out with kind of a big picture question. And that is, and I'll put this to Angela, what COVID-prompted changes are here to stay within Pfizer? And what activities might revert to normal when the pandemic recedes?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
